A utilização de polifarmácia pelos idosos e as alterações interindividuais na farmacodinâmica e farmacocinética, tornam estes pacientes mais vulneráveis a interações medicamentosas (IM) e resultados negativos da farmacoterapia. A glicoproteína P (P-gP) é
ADRIANO MAX MOREIRA REIS +3 more
doaj
Citroflavonoids as Promising Agents for Drug Discovery in Diabetes and Hypertension: A Systematic Review of Experimental Studies. [PDF]
Ortiz-Andrade R +5 more
europepmc +1 more source
Farmacogenética y medicina de laboratorio: del gen individual a los estudios genéticos integrales. [PDF]
Serra MB, García MI.
europepmc +1 more source
Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles. [PDF]
Ganse FG +16 more
europepmc +1 more source
[Selection of pharmacogenomic variants and methodology for their use in community pharmacy]. [PDF]
Montero-Gómez A, Sánchez Pozo A.
europepmc +1 more source
[Deprescription in old people: It's time to take action]. [PDF]
García Pliego RA +3 more
europepmc +1 more source
Use of Anticoagulant Therapy in Obese People: What is the Evidence for the Ideal Dose? [PDF]
Noya-Rabelo MM +3 more
europepmc +1 more source
An immunoproteomics approach to identify Leishmania infantum proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infection. [PDF]
Machado AS +16 more
europepmc +1 more source
[Impact of pharmaceutical care in polymedicated patients admitted to a geriatric ward]. [PDF]
Marín-Gorricho R +6 more
europepmc +1 more source

